Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 10 CNS 4 Breast 4 Gynecologic 2 Other hematologic neoplasm 1 Genitourinary 1 Dermatologic 1

Conditions

Prostatic Neoplasms 714 Carcinoma, Renal Cell 227 Urinary Bladder Neoplasms 211 Carcinoma, Transitional Cell 109 Breast Neoplasms 99 Kidney Neoplasms 96 Neoplasms 88 Carcinoma, Non-Small-Cell Lung 80 Melanoma 79 Ovarian Neoplasms 75 Neoplasm Metastasis 69 Colorectal Neoplasms 64 Non-Muscle Invasive Bladder Neoplasms 56 Lung Neoplasms 56 Pancreatic Neoplasms 50 Sarcoma 44 Endometrial Neoplasms 42 Stomach Neoplasms 40 Uterine Cervical Neoplasms 36 Adenocarcinoma 34 Carcinoma, Hepatocellular 32 Wilms Tumor 31 Esophageal Neoplasms 30 Squamous Cell Carcinoma of Head and Neck 27 Triple Negative Breast Neoplasms 26 Head and Neck Neoplasms 25 Colonic Neoplasms 24 Testicular Neoplasms 23 Neuroblastoma 23 Urologic Neoplasms 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Cognitive Dysfunction × Genitourinary × 90 days × Clear all

NCT05820932 2026-05-07

ABC

University of California, San Francisco

Prostatic Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡